Publication
Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression
Journal Paper/Review - Jan 1, 2017
Nitz U, Weiss E, Böhmer S, Kreienberg R, du Bois A, Sattler D, Thomssen C, Kiechle M, Jänicke F, Wallwiener D, Harbeck N, Hoffmann G, Augustin D, Möbus V, Gluz O, Huober Jens, Kreipe H H, Kates R E, Hartmann A, Erber R, Moustafa Z, Scholz M, Lisboa B, Mohrmann S, Kuhn W
Nitz, U
4
0
Gluz, O
3
0
Huober, Jens
chief physicianBrustzentrum St.Gallen, Medizinische Onkologie und Hämatologie · Dept. IV, Dept. I
288
11
Kreipe, H H
3
0
Kates, R E
3
0
Hartmann, A
6
0
Erber, R
3
0
Moustafa, Z
2
0
Scholz, M
2
0
Lisboa, B
2
0
Mohrmann, S
3
0
Möbus, V
9
0
Augustin, D
5
0
Hoffmann, G
4
0
Weiss, E
3
0
Böhmer, S
2
0
Kreienberg, R
6
0
du Bois, A
10
0
Sattler, D
3
0
Thomssen, C
10
0